This is a product which is the official product of the Mepiform with Safetac Technology 4"x7", 5 Count, Self Adherent Soft Silicone Sheeting for Scar Reduction. The official licensed Mepiform with Safetac Technology 4"x7", 5 Count, Self Adherent Soft Silicone Sheeting for Scar Reduction is made from 100% polyester and is made to generate maximum comfort, durability, and lightweight. It is cut snug so your body will be able to move freely.
Contains (5) sheets of 4"x7" self adherent, soft silicone dressing for reduction of hypertrophic and keloid scars. Mepiform is a self-adherent soft silicone dressing for scar care and was designed for the management of hypertrophic and keloid scars.
Topical silicone has empirically been shown to have positive impact in reducing hypertrophic and keloid scars. For optimum effect, Mepiform should be worn 24 hours a day. The thin, flexible design is discreet and may safely be worn during daily activities.
This is a product which is the official product of the Mepiform with Safetac Technology 4"x7", 5 Count, Self Adherent Soft Silicone Sheeting for Scar Reduction. The official licensed Mepiform with Safetac Technology 4"x7", 5 Count, Self Adherent Soft Silicone Sheeting for Scar Reduction is made from 100% polyester and is made to generate maximum comfort, durability, and lightweight. It is cut snug so your body will be able to move freely.
Mepiform minimizes pain & trauma at dressing changes & can be cut to size & reapplied. One Mepiform sheet may be used several days before replacement. It can also be used as prophylactic therapy on closed wounds to prevent hypertrophic or keloid scarring.
Mölnlycke Health Care is a world-leading provider of single-use surgical and wound care products for customers, healthcare professionals and patients. We develop and bring to market innovative wound care & surgical products for use in a range of settings.
We care about patients and customers and put them at the heart of everything we do. Our products provide value for money, supported by clinical and health economic evidence. We strive to find new ways to minimize community and hospital-acquired conditions.
